Entos Pharmaceuticals

The BIOTECanada Fall 2024 edition of Insights magazine via Issuu is now available digitally. Check out Entos Pharmaceuticals' article - pages 80-81 - where CEO John Lewis and CSO Arun Raturi describe our advanced precision medicines delivery platform!

Insights Fall 2024 Read Insights Fall 2024 by BIOTECanada on Issuu and browse thousands of other publications on our platform. Start here!

We are excited to share an article recently published in Nature Portfolio's Nature Reviews Drug Discovery by Katie Kingwell that highlights our breakthrough Fusogenix PLV delivery technology work for advanced therapeutics!
The original paper was published on Sept 19 in Cell by Cell Press and can also be found at: https://lnkd.in/gz6-ARd5.

A viral–lipid hybrid delivery system for genetic therapies https://lnkd.in/gCYA2YVR

A viral–lipid hybrid delivery system for genetic therapies Discover the world’s best science and medicine | Nature.com

San Diego's Good News of the Week – February 9, 2024 Every week, ‘Good News of the Week’ features a curation of positive headlines from San Diego, delivered straight to your inbox. A blend of aggregated stories from San Diego’s most trusted news sources and original EDC-created content, GNOTW provides a comprehensive recap of the region’s best...

Feb 1: Manufacturing Dive BRIEF published Feb 1, 2024: Entos Pharmaceuticalsopens Carlsbad, California facility.

Entos Pharmaceuticals opens California facility The Carlsbad facility will produce messenger RNA and plasmid DNA, part of a broader strategy to expand production in both the U.S. and Canada.